Nanopublication: RAUwXf4o2N

Full identifier: http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4

Raw formats: TriG(html,txt), JSON-LD(txt), N-Quads(txt), XML(txt)

Checking for updates...

 RAUwXf4o2N comment approve/disapprove edit as derived nanopublication

This is a local identifier minted within the nanopublication. http://purl.org/np/RAUwXf4o2N...#version version http://www.w3.org/ns/prov#value value (this is a literal) "1" .
http://www.w3.org/2000/01/rdf-schema#sentence sentence http://www.w3.org/2000/01/rdf-schema#label label (this is a literal) "Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus is responsible for the current pandemic - coronavirus disease 2019 (COVID)-19) plaguing the world Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus began spreading as early as January 2020 in the United States (US) and has recently become the leading cause of death amongst adults over 45 years of age Much of Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's clinical presentation is already known, and there have been advances in Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's successful treatment with a food and drug administration (FDA) approved antiviral medication called remdesivir, and other proven investigational methods with clinical benefits including dexamethasone and Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus antibody transfusion called convalescent plasma therapy However, the recommendations for other proven investigational methods with clinical benefits including dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy's use include COVID-19 confirmed patients requiring supplemental oxygen or other forms of respiratory support In this case report, we describe in detail a unique case of severe Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus infection that did not require any form of oxygen support hut was treated successfully with antiviral medications and steroids The purpose of this case report is to highlight in detail an unusual Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus presentation with rhabdomyolysis, myocarditis, and pancytopenia severe enough to require hospitalization and treatment with proven Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus therapy to achieve clinical resolution" .
This is the identifier for the assertion of this nanopublication. http://purl.org/np/RAUwXf4o2N...#assertion this assertion http://www.w3.org/ns/prov#wasGeneratedBy wasGeneratedBy (this is a literal) "S&T TWOC project version 1" .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAUwXf4o2N...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAUwXf4o2N... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAUwXf4o2N...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

Eva Zegelaar, 25 Jul 2021, 21:47:44 UTC

show references